Searched for
GLENMARK PHARMACEUTICAL LTD
For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%All is once again quiet on the US-Iran war front, and some kind of dialogue to resolve the issues between the two seems to be still underwa...- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- Capitalmind Flexi Cap Fund adds Nestle India and 10 others, exits SBI and 14 others in MayCapitalmind Flexi Cap Fund made significant portfolio adjustments in May. The fund welcomed Nestle India and eleven new stocks. It also div...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Capitalmind Flexi Cap Fund exits RIL and 2 others, hikes stake in Titan Company, MCX and 16 other stocks in AprilCapitalmind Flexi Cap Fund exited Reliance Industries, Bank of Baroda, and L&T Finance in April. The fund also increased stakes in Titan Co...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- I-Sec maintains Reduce call on Glenmark Pharma, raises target price to Rs 1,300ICICI Securities maintains a Reduce call on Glenmark Pharmaceuticals, revising the target price to Rs 1,300. The brokerage anticipates reve...
- Reduce Glenmark Pharmaceuticals, target price Rs 1,265: ICICI SecuritiesICICI Securities maintains a Reduce call on Glenmark Pharmaceuticals with a target price of Rs 1,265. The current market price is Rs 1365.9...
- Glenmark Pharmaceuticals Q3 Results: PAT at Rs 348 crore versus YoY loss, revenue up 35%Glenmark Pharmaceuticals Q3 Results: Glenmark Pharmaceuticals posted a net profit of ₹348 crore in Q3 FY25, reversing a ₹351 crore loss YoY...
- Buy Glenmark Pharmaceuticals, target price Rs 1,779: Choice Equity BrokingChoice Equity Broking has issued a buy call for Glenmark Pharmaceuticals, setting a target price of Rs 1,779. The brokerage projects robust...
- Reduce Glenmark Pharmaceuticals, target price Rs 780: ICICI SecuritiesGlenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the y...
- Reduce Glenmark Pharmaceuticals, target price Rs 660: ICICI SecuritiesGlenmark Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue and Sale of services for the y...
- Glenmark Pharmaceuticals launches generic version of diuretic Bumetanide injectionThe launch affirms commitment to Glenmark's continued focus on institutional business, company Senior Vice President, Business Development ...
- Buy Glenmark Pharmaceuticals Ltd with a target of Rs 749: Sandeep Wagle'Glenmark Pharmaceuticals Ltd is a 'BUY' call with a target of Rs 759 and a stop loss of Rs 725.'
- Buy Glenmark Pharmaceuticals Ltd with a target of Rs 749: Sandeep Wagle'Glenmark Pharmaceuticals Ltd is a 'BUY' call with a target of Rs 749 and a stop loss of Rs 732.'
- Buy Glenmark Pharmaceuticals Ltd with a target of Rs 752: Mitesh Thacker'Glenmark Pharmaceuticals Ltd is a 'BUY' call with a target of Rs 752 and a stop loss of Rs 721.'
- Glenmark Pharmaceuticals gains 7% on Q2 results; brokerages maintain buyThe company had posted a net profit of Rs 56.58 crore for the quarter ended September 30, 2011, Glenmark Pharmaceuticals said in a statemen...
- Glenmark Pharmaceuticals Q2 net up nearly three fold at Rs 156.75 crGlenmark Pharmaceuticals today said its consolidated net profit rose by nearly three fold to Rs 156.75 crore for the quarter ended Septembe...
Load More
